// App-Quantinova.ai

: Clinical Features and Treatment Response in Patients with Multiple Myeloma and CD20 Expression: Real-Life Experience of the Centro-Italy Multiple Myeloma Macroregional District

Researchers

Presenter

  • Alessia Fiorini

Principal Investigators

  • Maria Gabriela Chavez

  • Iole Cordone

  • Guido Montanaro

  • Francesca Fazio

  • Loredana Bassi

  • Valeria Tomarchio

  • Edoardo Sbraga

  • Monica Poscente

  • Roberta Merola

  • Maria Stefania De Propris

  • Andrea Mengarelli

  • Stefano Licci

  • Raffaella Giancola

  • Roberto Latagliata

  • Ombretta Annibali

  • Angela Rago

  • Francesca Fioritoni

  • Maria Teresa Petrucci

  • Alessandro Andriani

Medical Centers

  • IRCCS Regina Elena National Cancer Institute, Rome, ITA

  • Unit of Hematology, Stem Cell Transplantation, University Campus Bio Medico, Rome, Italy

  • UOC Diagnostica Clinica, Laboratorio di Citofluorimetria, Belcolle Hospital, Viterbo, Italy

  • UOC Hematology - Mieloma Unit, Belcolle Hospital, ASL VT, Viterbo, Italy

  • UOSD Laboratorio Genetica Medica, Belcolle Hospital, Viterbo, Italy

  • Hematology, IRCCS Regina Elena National Cancer Institute, Rome, Rome, Italy

  • Hematology, Department of Translational and Precision Medicine, Azienda Ospedaliera Policlinico Umberto I, Sapienza University of Rome, Rome, Italy

  • UOSD Ematologia, ASL Roma , Rome, Italy

  • Hematology, Belcolle Hospital, Viterbo, Italy

  • Hematology Unit, Department of Oncology Hematology, Pescara Hospital, Pescara, Italy

  • Hematology, Belcolle Hospital, Viterbo, ITA

Locations

  • United States

  • Italy

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Multiple Myeloma

Biomarkers

  • p53

  • B-lymphocyte antigen CD20

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved